X

pharmaceuticals

AbbVie (ABBV) to focus more on pipeline as recovery gathers pace

AbbVie, Inc. (NYSE: ABBV) has been recovering steadily from the virus-related slowdown and latest statistics show that the company's performance…

Eagle Pharmaceuticals Inc. (EGRX) Q3 2020 Earnings Call Transcript

Eagle Pharmaceuticals Inc.  (NASDAQ: EGRX) Q3 2020 Earnings Call dated Nov. 02, 2020 Corporate Participants: Lisa M. Wilson -- Investor Relations -…

AbbVie shares gain after Q3 results beat estimates: Infographic

AbbVie (NYSE: ABBV) reported third-quarter 2020 financial results before the regular trading hours on Friday. The pharmaceutical behemoth reported Q3…

Infographic: Highlights of Gilead Sciences (GILD) Q3 earnings report

Biopharmaceutical company  Gilead Sciences Inc (NASDAQ: GILD) Wednesday said its third-quarter earnings increased, aided by higher revenues. The results also…

Pfizer (PFE) posts mixed results in Q3

Pfizer Inc (NYSE: PFE) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported a…

Infographic: Highlights of Merck & Co. (MRK) Q3 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported stronger than expected earnings and sales for the third quarter of 2020. The…

Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript

Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara -- Head of Investor Relations Michel Vounatsos -- Chief…

Earnings: Intuitive Surgical (ISRG) Q3 results exceed estimates

Intuitive Surgical Inc. (NASDAQ: ISRG) reported lower earnings and revenues for the third quarter of 2020, hurt by the coronavirus-related…

Johnson & Johnson (JNJ) Q3 earnings: Infographic

Johnson & Johnson (NYSE: JNJ) reported third-quarter 2020 financial results before the opening bell on Tuesday. The pharmaceutical giant reported…

AstraZeneca stock looks a good bet as COVID antibody drug brings fresh hope

With the pandemic situation showing little signs of improvement, healthcare institutions are under pressure to expedite their vaccine development programs,…

UnitedHealth Group (UNH) is headed for a weak second half. Here’s why

For UnitedHealth Group Inc. (NYSE: UNH), the early effect of coronavirus on its business was a marked reduction in costs…

Bristol Myers looks to expand cardiovascular portfolio with MyoKardia acquisition

Bristol Myers Squibb (NYSE: BMY) agreed to acquire MyoKardia Inc. (NASDAQ: MYOK) for $13.1 billion in cash. The deal, which…

After initial hiccups, Cigna (CI) looks to emerge healthier post-COVID

The healthcare sector was required to respond to the coronavirus outbreak in a proactive manner, unlike most other businesses. Cigna…

AMAG Pharmaceuticals Inc (AMAG) Q2 2020 Earnings Call Transcript

AMAG Pharmaceuticals Inc (NASDAQ: AMAG) Q2 2020 earnings call dated August 06, 2020 Corporate Participants: Rushmie Nofsinger -- Executive Director of Corporate…

What makes CVS Health a better investment option than Walgreens

https://www.youtube.com/watch?v=WOSh4S0zUds For healthcare systems across the world, currently, the first priority is to find an effective treatment for coronavirus, at…

Rite Aid Corp (RAD) Q2 2021 Earnings Call Transcript

Rite Aid Corp (NYSE: RAD) Q2 2021 earnings conference call dated September 24, 2020   Corporate Participants: Trent Kruse -- Senior Vice…

Rite Aid’s (RAD) loss narrows in Q2 2021

Rite Aid Corporation (NYSE: RAD) reported a narrower loss in the second quarter of 2021. Net loss shrank to $0.25…

Aurora Cannabis (ACB) banks on premium brands after disastrous Q4

Shareholders of Aurora Cannabis (NYSE: ACB) were dealt an unexpected blow this week as the pot company's disappointing earnings report…

Aurora Cannabis Inc. (ACB) Q4 2020 Earnings Call Transcript

Aurora Cannabis Inc  (NYSE: ACB) Q4 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Miguel Martin -- Chief Executive Officer and…

Highlights of Aurora Cannabis (ACB) Q4 2020 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a wider loss for the fourth quarter of 2020, hurt by a 5% decrease…

ERYTECH Pharma S.A. (ERYP) Q2 2020 Earnings Call Transcript

ERYTECH Pharma S.A. (NASDAQ: ERYP) Q2 2020 earnings call dated Sep. 22, 2020 Corporate Participants: Gil Beyen -- Chief Executive Officer Eric…